Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 1;125(4):1277-1283.
doi: 10.1152/japplphysiol.00454.2018. Epub 2018 Aug 2.

Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis

Affiliations
Free article

Cardiopulmonary exercise testing with supramaximal verification produces a safe and valid assessment of V̇o2max in people with cystic fibrosis: a retrospective analysis

Adam J Causer et al. J Appl Physiol (1985). .
Free article

Abstract

The validity and safety of using supramaximal verification (Smax) to confirm a maximal effort during cardiopulmonary exercise testing (CPET) in people with cystic fibrosis (CF) and/or those with severe disease has been questioned. Therefore, this study aimed to investigate these concerns in children, adolescents, and adults with mild-to-severe CF lung disease. Retrospective analysis of 17 pediatric and 28 adult participants with CF [age range: 9.2-62.9 y; forced expiratory volume in 1 s: 66.7% (range: 29.9%-102.3%); 30 men] who completed a routine ramp-incremental cycling test to determine peak oxygen uptake (V̇o2peak) was studied. Maximal oxygen uptake (V̇o2max) was subsequently confirmed by Smax at 110% of peak power output. All participants satisfied the criteria to verify a maximal effort during CPET. However, Smax-V̇o2peak exceeded ramp-V̇o2peak in 3/14 (21.4%) of pediatric and 6/28 (21.4%) adult exercise tests. A valid measurement of V̇o2max was attained in 85.7% of pediatric and 96.4% of adult exercise tests, as Smax-V̇o2peak did not exceed ramp-V̇o2peak by >9%. Adults ( n = 9) experienced a ≥5% reduction in arterial O2 saturation during CPET, 4 during both the ramp and Smax, 3 during only the ramp, and 2 during only Smax. Smax did not significantly worsen perceived breathing effort, chest tightness, throat narrowing, or exertion compared with ramp-incremental testing. Given the clinical importance of aerobic fitness in people with CF, incorporating Smax is recommended to provide a safe and valid measure of V̇o2max in children, adolescents, and adults who span the spectrum of CF disease severity. NEW & NOTEWORTHY Incorporating supramaximal verification into cardiopulmonary exercise testing protocols did not increase the frequency of adverse events or perceived discomfort versus a single-phase incremental exercise test in people with mild-to-severe cystic fibrosis. Furthermore, a valid measure of maximal oxygen uptake (V̇o2max) was obtained from 85.7% of pediatric and 96.4% of adult exercise tests, whereas peak oxygen uptake underestimated aerobic fitness in comparison with V̇o2max in 21.4% of cases (by up to 24.4%).

Keywords: cardiorespiratory fitness; maximal oxygen uptake; peak oxygen uptake; respiratory disease.

PubMed Disclaimer

Comment in

  • Supramax exercise testing in cystic fibrosis: not ready for prime time.
    Cooper DM. Cooper DM. J Appl Physiol (1985). 2019 Jan 1;126(1):264. doi: 10.1152/japplphysiol.00782.2018. J Appl Physiol (1985). 2019. PMID: 30694710 Free PMC article. No abstract available.
  • Reply to Cooper.
    Causer AJ, Shute JK, Cummings MH, Shepherd AI, Bright V, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL. Causer AJ, et al. J Appl Physiol (1985). 2019 Jan 1;126(1):265. doi: 10.1152/japplphysiol.00839.2018. J Appl Physiol (1985). 2019. PMID: 30694712 No abstract available.
  • Confirming V̇o2max without bias.
    Askew CD, Green S. Askew CD, et al. J Appl Physiol (1985). 2019 Feb 1;126(2):511. doi: 10.1152/japplphysiol.00883.2018. J Appl Physiol (1985). 2019. PMID: 30799674 No abstract available.
  • Reply to Askew and Green.
    Causer AJ, Shute JK, Cummings MH, Shepherd AI, Bright V, Connett G, Allenby MI, Carroll MP, Daniels T, Saynor ZL. Causer AJ, et al. J Appl Physiol (1985). 2019 Feb 1;126(2):512. doi: 10.1152/japplphysiol.00939.2018. J Appl Physiol (1985). 2019. PMID: 30799675 No abstract available.

Publication types

LinkOut - more resources